Back to Results
First PageMeta Content
Androgens / Testosterone / Neuroendocrinology / Hypogonadism / Prostate cancer / Food and Drug Administration / Androgen replacement therapy / Medicine / Andrology / Endocrine system


DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993
Add to Reading List

Open Document

File Size: 28,34 KB

Share Result on Facebook

Company

Special Medical Programs / Clarus Therapeutics / J.D. Associate / /

Country

United States / /

Currency

USD / /

Event

Product Issues / /

Facility

Beth Israel Deaconess Medical Center / /

IndustryTerm

therapies for prostate cancer / treatment for cancer / /

MedicalCondition

cancer / disease / diabetes / urologic cancer / injury / obesity / testosterone deficiency / hypogonadotropic hypogonadism / primary hypogonadism / high blood pressure / deficiency / prostate cancer / urologic conditions causing testosterone deficiency / United States experience testosterone deficiency / primary and hypogonadotropic hypogonadism / specifically prostate cancer / /

MedicalTreatment

radiation treatment / testosterone replacement therapy / chemotherapy / hormonal therapies / /

Organization

Harvard Medical School / Drug Safety and Risk Management Advisory Committee / Food and Drug Administration / Ethics and Integrity office of Operations Michael F. Ortwerth / Bone / Reproductive and Urologic Drugs Advisory Committee / Management Staff Office / Consultant Management Office / Beth Israel Deaconess Medical Center in Boston / Risk Management Advisory Committee / DEPARTMENT OF HEALTH / Advisory Committee / Executive Programs Center for Drug Evaluation / /

Person

Silver Spring / Michael F. Ortwerth / Jill Hartzler Warner / Marc Garnick / Jayne E. Peterson / Vince Tolino / /

Position

Director / Division / Director / Commissioner / researcher / Professor of Medicine / J.D. / B.S.Pharm Director / Division / /

Product

testosterone / cancer / /

Technology

radiation / chemotherapy / /

SocialTag